×

Inside Kite Pharma's 100% run

7:51 AM ET Wed, 24 June 2015

CNBC's Meg Tirrell takes a look at what's driving shares of Kite Pharma higher, as the biotech company announces it is joining forces with Bluebird to collaborate on cancer T-cell therapies.